What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary scientific interests are in Internal medicine, Surgery, Cancer, Prospective cohort study and Risk factor.
His work deals with themes such as Gastroenterology, Gynecology and Oncology, which intersect with Internal medicine.
His work carried out in the field of Surgery brings together such families of science as Gastrectomy, Clinical trial and Lymphadenectomy.
His Cancer research is mostly focused on the topic Stomach cancer.
His study in Prospective cohort study is interdisciplinary in nature, drawing from both Diet Records, Epidemiology, Relative risk, Isoflavones and Cohort.
His biological study spans a wide range of topics, including Odds ratio, Intestinal mucosa and Cohort study.
His most cited work include:
- Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer (1055 citations)
- D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. (719 citations)
- Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer (654 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Surgery, Colorectal cancer, Cancer and Oncology are his primary areas of study.
His Internal medicine study frequently draws connections between related disciplines such as Gastroenterology.
His research links Colectomy with Surgery.
His studies examine the connections between Colorectal cancer and genetics, as well as such issues in Lymph node, with regards to Dissection and Lymphovascular invasion.
His work in Cancer covers topics such as Risk factor which are related to areas like Odds ratio.
His research integrates issues of Gastrectomy and Clinical trial in his study of Randomized controlled trial.
He most often published in these fields:
- Internal medicine (38.82%)
- Surgery (37.50%)
- Colorectal cancer (27.63%)
What were the highlights of his more recent work (between 2015-2020)?
- Surgery (37.50%)
- Colorectal cancer (27.63%)
- Internal medicine (38.82%)
In recent papers he was focusing on the following fields of study:
His main research concerns Surgery, Colorectal cancer, Internal medicine, Randomized controlled trial and Radiology.
The Surgery study combines topics in areas such as Rectal carcinoma and Subgroup analysis.
His Colorectal cancer research includes themes of Rectum, Lymph node, Propensity score matching, General surgery and Dissection.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Oncology.
His Randomized controlled trial study combines topics in areas such as Physical therapy and Survival analysis.
His Cancer study incorporates themes from Clinical research, Quality of life, Gynecology and Intention-to-treat analysis.
Between 2015 and 2020, his most popular works were:
- Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial (209 citations)
- Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. (129 citations)
- Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial (94 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
The scientist’s investigation covers issues in Surgery, Randomized controlled trial, Laparoscopic surgery, Colorectal cancer and Clinical trial.
His Surgery research incorporates themes from Colectomy, Subgroup analysis and Low rectal cancer.
His Randomized controlled trial research is multidisciplinary, incorporating elements of Psychological intervention and Survival analysis.
Colorectal cancer is a subfield of Internal medicine that Seiichiro Yamamoto investigates.
His work on Internal medicine is being expanded to include thematically relevant topics such as Gynecology.
His Clinical endpoint study in the realm of Clinical trial interacts with subjects such as Attendance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
